Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Kim, Seung Jun ^a   Oh, Hyung Jung ^a   Yoo, Dong Eun ^a   Shin, Dong Ho ^a   Lee, Mi Jung ^a   Kim, Hyoung Rae ^a   Park, Jung Tak ^a   Han, Seung Hyeok ^a   Yoo, Tae Hyun ^a   Choi, Kyu Hun ^a   Kang, Shin Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORNELL VOLTAGE; CORNELL VOLTAGE DURATION PRODUCT; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GENDER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE REVASCULARIZATION; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; LEFT ATRIAL VOLUME INDEX; MAJOR CLINICAL STUDY; MALE; MITRAL INFLOW VELOCITY TO PEAK MITRAL ANNULUS VELOCITY RATIO; MORTALITY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; QT INTERVAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SOKOLOW LYON VOLTAGE; SOKOLOW LYON VOLTAGE DURATION PRODUCT; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; ROC CURVE; YOUNG ADULT;

EID: 84859977227     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035534     Document Type: Article

References (39)

1. Foley RN, Parfrey PS, Sarnak MJ, (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: S112-119.
2. Middleton RJ, Parfrey PS, Foley RN, (2001) Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12: 1079-1084.
3. Levin A, Djurdjev O, Thompson C, Barrett B, Ethier J, et al. (2005) Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis 46: 799-811.
4. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, et al. (1995) Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192.
5. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, et al. (1999) Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34: 125-134.
6. Silberberg JS, Barre PE, Prichard SS, Sniderman AD, (1989) Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290.
7. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, et al. (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12: 2759-2767.
8. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, et al. (2004) Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 65: 1492-1498.
9. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, et al. (2005) Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293: 1737-1745.
10. Glassock RJ, Pecoits-Filho R, Barberato SH, (2009) Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 4 (Suppl 1): S79-91.
11. Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, et al. (2009) Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 296: H585-593.
12. Martin LC, Franco RJ, Gavras I, Matsubara BB, Garcia S, et al. (2004) Association between hypervolemia and ventricular hypertrophy in hemodialysis patients. Am J Hypertens 17: 1163-1169.
13. MacRae JM, Levin A, Belenkie I, (2006) The cardiovascular effects of arteriovenous fistulas in chronic kidney disease: a cause for concern? Semin Dial 19: 349-352.
14. Fujii H, Kim JI, Abe T, Umezu M, Fukagawa M, (2007) Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis patients. Intern Med 46: 1507-1512.
15. Gross ML, Ritz E, (2008) Hypertrophy and fibrosis in the cardiomyopathy of uremia-beyond coronary heart disease. Semin Dial 21: 308-318.
16. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP, (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566.
17. Stewart GA, Foster J, Cowan M, Rooney E, McDonagh T, et al. (1999) Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int 56: 2248-2253.
18. Truong QA, Ptaszek LM, Charipar EM, Taylor C, Fontes JD, et al. (2010) Performance of electrocardiographic criteria for left ventricular hypertrophy as compared with cardiac computed tomography: from the Rule Out Myocardial Infarction Using Computer Assisted Tomography trial. J Hypertens 28: 1959-1967.
19. Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, et al. (1985) Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 6: 572-580.
20. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, et al. (1990) Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 81: 815-820.
21. Okin PM, Roman MJ, Devereux RB, Kligfield P, (1995) Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 25: 417-423.
22. Calderon A, Barrios V, Escobar C, Ferrer E, Barrios S, et al. (2010) Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study. Clin Exp Hypertens 32: 145-153.
23. Okin PM, Devereux RB, Jern S, Julius S, Kjeldsen SE, et al. (2001) Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Am J Hypertens 14: 775-782.
24. Agarwal R, Light RP, (2011) Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease. Clin J Am Soc Nephrol 6: 528-536.
25. Gotch FA, Sargent JA, (1985) A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28: 526-534.
26. Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, et al. (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 53: 982-991.
27. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450-458.
28. Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, Ghali JK, (1997) Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 29: 641-647.
29. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, et al. (2003) Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14: 3270-3277.
30. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, et al. (2004) Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 65: 2380-2389.
31. Krane V, Heinrich F, Meesmann M, Olschewski M, Lilienthal J, et al. (2009) Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol 4: 394-400.
32. Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlof B, (2000) Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients: the losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension 35: 13-18.
33. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, et al. (2001) Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 104: 1615-1621.
34. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, et al. (2004) Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 292: 2343-2349.
35. (2005) K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45: S1-153.
36. Molloy TJ, Okin PM, Devereux RB, Kligfield P, (1992) Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 20: 1180-1186.
37. Barrios V, Escobar C, Calderon A, Tomas JP, Ruiz S, et al. (2006) Regression of left ventricular hypertrophy by a candesartan-based regimen in clinical practice. The VIPE study. J Renin Angiotensin Aldosterone Syst 7: 236-242.
38. Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, et al. (1993) The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 65: 212-214.
39. Willems JL, Poblete PF, Pipberger HV, (1972) Day-to-day variation of the normal orthogonal electrocardiogram and vectorcardiogram. Circulation 45: 1057-1064.